Relmada Therapeutics Inc Balance Sheet Statement

RLMD $34.23 1.0 3.0%

05/03/21

Speculative, Mid Cap, Sucker Stock

Market Cap £401.7m

Enterprise Value £312.7m

Revenue £n/a

Quality

Value

Momentum

StockRank™

To unlock Relmada Therapeutics Inc's balance sheet statement please upgrade your membership.

	2015	2016	2017	2018	2019	2019
Period End:	2015-06-30	2016-06-30	2017-06-30	2018-06-30	2019-06-30	2019-12-31
Period Length:	0	0	0	0	0	0
Currency:	USD	USD	USD	USD	USD	USD

Cash & Equivalents
Short Term Investments
Cash and Short Term Investments
Total Receivables, Net
Prepaid Expenses
Total Current Assets

Property/Plant/Equipment, Total - Gross
Accumulated Depreciation, Total
Property/Plant/Equipment, Total - Net
Note Receivable - Long Term
Other Long Term Assets, Total
Total Assets

Accounts Payable
Accrued Expenses
Notes Payable/Short Term Debt
Other Current Liabilities, Total
Total Current Liabilities

Long Term Debt
Total Long Term Debt
Total Debt
Other Liabilities, Total
Total Liabilities

Redeemable Preferred Stock
Common Stock
Additional Paid-In Capital
Retained Earnings (Accumulated Deficit)
Total Equity

Total Liabilities & Shareholders’ Equity
Total Common Shares Outstanding
Total Preferred Shares Outstanding

Unlock Stockopedia Premium for free!

See what it can do for your stockpicking and portfolio at no expense.